Go to the profile of Novocure

Novocure

 
  • United States of America

About Novocure

Novocure is an oncology company developing a profoundly different cancer treatment utilizing a proprietary therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product, Optune, is approved for the treatment of adult patients with glioblastoma. Novocure has ongoing or completed clinical trials investigating TTFields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and mesothelioma.

Therapeutic Areas

Oncology

Technologies

Other

Company Type

Biotechnology – Therapeutics

State of Ownership

Other

Sponsorship Group

Networker

Topics

Topics contributed to:

MedTech Dealmakers

Editions participated in:

MedTech 2017